Trials

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

Cancer type: Melanoma

Phase: I

Principal Investigator: Nyakas Martha

Country: NO

Keywords: Norway, Oslo University Hospital, BRAF mutant, BRAF mutated, melanoma, metastatic, Oslo

Status: Completed

Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01436656?term=CLGX818X2101&rank=1